Lipid lowering combination therapy: From prevention to atherosclerosis plaque treatment
Statins have contributed to the prevention of numerous atherosclerotic cardiovascular (CV) events and cardiovascular deaths in the past three decades. The benefit of statins is mainly mediated by the lowering of LDLc. According to scientific evidence, the current international guidelines recommend v...
Saved in:
Main Authors: | Lluís Masana (Author), Núria Plana (Author), Natalia Andreychuk (Author), Daiana Ibarretxe (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unsolved Issues of Atherosclerosis Prevention and of Adequate Lipid-lowering Therapy in Patients with Acute Ischemic Cerebrovascular Accident
by: S. A. Boytsov, et al.
Published: (2022) -
Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis
by: N. E. Gavrilova, et al.
Published: (2015) -
Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis
by: N. E. Gavrilova, et al.
Published: (2015) -
Intensive lipid lowering agents and coronary atherosclerosis: Insights from intravascular imaging
by: Giuseppe Di Giovanni, et al.
Published: (2022) -
Atherosclerotic coronary plaque regression from lipid-lowering therapies: A meta-analysis and meta-regression
by: Frederick Berro Rivera, et al.
Published: (2024)